Stryker Lifts Organic Sales Outlook After 1Q Rise
By Ben Glickman
Stryker raised its full-year forecast for organic sales growth after its first-quarter profit and revenue both rose more than expected.
The Portage, Mich.-based medical technology company reported a profit of $788 million, or $2.05 a share, in the quarter ended March 31, compared with a profit of $592 million, or $1.54 a share, a year earlier. Analysts polled by FactSet expected a per-share profit of $1.99.
Stripping out certain one-time items, the company posted an adjusted per-share profit of $2.50, ahead of the $2.36 expected by analysts surveyed by FactSet.
Revenue rose 9.7% to $5.24 billion, beating the $5.1 billion expected by analysts polled by FactSet.
Stryker's organic sales were up 10% in the period, almost all of which was from increases to sales volume. Analysts polled by FactSet expected organic sales to be up about 7.3%.
The company's MedSurg and Neurotechnology sales were up 11.5%, while orthopaedics and spine sales had slower growth.
The company said it expects organic sales to be up 8.5% to 9.5% for 2024, compared to its previous outlook for a 7.5% to 9% increase.
Stryker also lifted its full-year forecast for adjusted per-share earnings to $11.85 to $12.05, compared with a previous guidance range of $11.70 to $12.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
April 30, 2024 16:34 ET (20:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations